Univ.-Prof. Dr. Ina Bergheim

Research projects Univ.-Prof. Dr. Ina Bergheim

ongoing research projects

2021-2024: “Xanthohumol and viral infections”

funded by FWF, Der Wissenschaftsfonds

2021-2024: “Aging and bacterial endotoxin”

funded by FWF, Der Wissenschaftsfonds

2020 - 2024: “MC Smart Age” Gut-brain-axis: Targets for improvement of cognition in the elderly

EU Project H2020 – Marie Sklodowska-Curie

2019-2022: "Endogenous Alcohol in NAFLD“

funded by FWF, Der Wissenschaftsfonds

2018-2021: "INTIMIC - Dietary modulation of intestinal microbiota as trigger of liver health: role of bile acids (Di-Mi-Liv) (Betaglucan)"

HDHL INTIMIC Knowledge Platform on Food, Diet, Intestinal Microbiomics and Human Health

funded by FFG, Österreichische...

2019 - 2020: „Analysis of the synergistic anti-inflammatory effect of the hop derived beer compounds iso-alpha-acids and xanthohumol”

Joint ERAB / EBC GRANT 2018

Grant Agreement Universität Wien – Friedrich Alexander-Universität Erlangen-Nürnberg

2018: “Nuces NAFLD II” Nutritional Counseling versus Nutritional Supplements in NAFLD treatment - A Pilot, Prospective, Randomized, Open Label Study

Grant Yakult Europe B.V., The Netherlands

Grant Agreement Universität Wien –Universität Mainz

2016-2019: "Aging-associated modification of intestinal homeostasis and barrier function: Role of microbiota, iNOS and innate immunity"

subproject of the DFG Priority Program 1656

2015-2018: "Effects of an oral supplementation of arginine, citrulline and glutamine on the development and progression of non-alcoholic fatty liver disease (NAFLD): Role of gender and age"

funded by Deutsche Forschungsgemeinschaft (DFG)

2015-2017: "Effect of chronic beer consumption on liver metabolism: Role of hop components"

funded by Wissenschaftsförderung der deutschen Brauwirtschaft (WDB)

2012-2016: "Role of hepatic toll-like receptors in the development of obesity-associated fatty liver disease" (KN Adipositas) funded by Bundesministerium für Bildung und Forschung (BMBF)

funded by Bundesministerium für Bildung und Forschung (BMBF)

2012-2016: "From intestinal inflammation to obesity-associated liver disease (OBIHEP)" (International Joint META-Call, Coordinator: Bergheim)

funded by Bundesministerium für Bildung und Forschung (BMBF)

2012-2013: "Effect of acute pils consumption on liver metabolism: Role of NFκB"

funded by Wissenschaftsförderung der deutschen Brauwirtschaft (WDB)

2011-2013: "Plasminogen activator inhibitor 1 (PAI)-1 in the pathogenesis of non-alcoholic fatty liver disease: Regulation of CD1d and NKT cells in liver"

funded by Deutsche Forschungsgemeinschaft (DFG)

2010-2013: "Pathogenesis of fructose-induced non-alcoholic fatty liver disease (NAFLD): Studies of protective effects of supplementation of arginine, citrulline and glutamine"

funded by Deutsche Forschungsgemeinschaft (DFG)

2010-2011: "Effect of chronic beer consumption on liver metabolism: Role of hop components"

funded by Wissenschaftsförderung der deutschen Brauwirtschaft (WDB)

2008-2013: "Non-alcoholic fatty liver disease (NAFLD): Molecular mechanisms and nutrition-based prevention" (Young researcher group)

funded by Bundesministerium für Bildung und Forschung (BMBF)

2008-2010: "Role of plasminogen activator inhibitor 1 (PAI-1) in the pathogenesis of liver diseases"

funded by Deutsche Forschungsgemeinschaft (DFG)

Research projects Univ.-Prof. Dr. Ina Bergheim

ongoing research projects

2021-2024: “Xanthohumol and viral infections”

2021-2024: “Aging and bacterial endotoxin”

2020 - 2024: “MC Smart Age” Gut-brain-axis: Targets for improvement of cognition in the elderly

2019-2022: "Endogenous Alcohol in NAFLD“

2018-2021: "INTIMIC - Dietary modulation of intestinal microbiota as trigger of liver health: role of bile acids (Di-Mi-Liv) (Betaglucan)"

completed research projects

2019 - 2020: „Analysis of the synergistic anti-inflammatory effect of the hop derived beer compounds iso-alpha-acids and xanthohumol”

2018: “Nuces NAFLD II” Nutritional Counseling versus Nutritional Supplements in NAFLD treatment - A Pilot, Prospective, Randomized, Open Label Study

2016-2019: "Aging-associated modification of intestinal homeostasis and barrier function: Role of microbiota, iNOS and innate immunity"

2015-2018: "Effects of an oral supplementation of arginine, citrulline and glutamine on the development and progression of non-alcoholic fatty liver disease (NAFLD): Role of gender and age"

2015-2017: "Effect of chronic beer consumption on liver metabolism: Role of hop components"

2012-2016: "Role of hepatic toll-like receptors in the development of obesity-associated fatty liver disease" (KN Adipositas) funded by Bundesministerium für Bildung und Forschung (BMBF)

2012-2016: "From intestinal inflammation to obesity-associated liver disease (OBIHEP)" (International Joint META-Call, Coordinator: Bergheim)

2012-2013: "Effect of acute pils consumption on liver metabolism: Role of NFκB"

2011-2013: "Plasminogen activator inhibitor 1 (PAI)-1 in the pathogenesis of non-alcoholic fatty liver disease: Regulation of CD1d and NKT cells in liver"

2010-2013: "Pathogenesis of fructose-induced non-alcoholic fatty liver disease (NAFLD): Studies of protective effects of supplementation of arginine, citrulline and glutamine"

2010-2011: "Effect of chronic beer consumption on liver metabolism: Role of hop components"

2008-2013: "Non-alcoholic fatty liver disease (NAFLD): Molecular mechanisms and nutrition-based prevention" (Young researcher group)

2008-2010: "Role of plasminogen activator inhibitor 1 (PAI-1) in the pathogenesis of liver diseases"